# OnCo record suzanne-topalian (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/suzanne-topalian/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "suzanne-topalian" ;
  schema:name "Suzanne L. Topalian"@en ;
  schema:description "Suzanne Topalian led the first nivolumab trials showing PD-1 blockade works across several cancers."@en ;
  schema:url <https://onco.cc/people/suzanne-topalian/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Suzanne_L._Topalian> ;
  schema:citation <https://www.hopkinsmedicine.org/profiles/details/suzanne-topalian>, <https://pubmed.ncbi.nlm.nih.gov/?term=Topalian%20SL%5BAuthor%5D> ;
  schema:jobTitle "Bloomberg~Kimmel Professor of Cancer Immunotherapy; Associate Director, Bloomberg~Kimmel Institute" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/rcc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:institutions <https://onco.cc/institutions/johns-hopkins/> ;
  schema:affiliation <https://onco.cc/institutions/johns-hopkins/> .